Corporate Lawyers Belgium 2026: BCCA Amendments, Director Duties and M&A Risks

The Belgian Code of Companies and Associations (BCCA) is undergoing its most significant revision since the statute’s original adoption, and corporate lawyers Belgium-wide are advising boards and deal teams to act now. A draft bill tabled in early 2026 proposes far-reaching changes to director duties, governance mechanics, disclosure obligations and minority-shareholder protections, each of which feeds directly into how M&A transactions are structured, negotiated and closed. Overlapping tax measures, including revised capital-gains treatment and mandatory e-invoicing requirements, add further complexity to deal economics. This guide provides the practitioner-level analysis that in-house counsel, private-equity sponsors and general counsel need to re-evaluate transaction risk, update warranty packages and ensure board-level compliance before the amendments take effect.

Executive TL;DR: The 2026 BCCA bill raises the bar on director care and diligence, introduces tighter criminal-liability triggers, expands disclosure duties for private limited companies (SRL/BV) and public companies (NV/SA) alike, and reshapes minority-protection rules that directly affect squeeze-out mechanics and shareholder consent thresholds. Deal teams should (1) revise standard due-diligence requests to capture new compliance obligations, (2) update warranty and indemnity schedules to allocate newly crystallised director risk, and (3) ensure pre-completion board resolutions expressly reference the amended BCCA provisions.

Overview of the 2026 BCCA Amendments, What Changed and Why It Matters

Belgium’s company law framework, the Code of Companies and Associations (Wetboek van vennootschappen en verenigingen), was enacted on 23 March 2019 and published in the Moniteur Belge (Belgian Official Gazette). The draft bill tabled in early 2026 proposes targeted amendments to several core chapters. For corporate lawyers Belgium transactions rely upon, these changes alter the risk profile of virtually every deal component, from formation and capital adequacy through to exit and squeeze-out.

The principal categories of amendment can be summarised as follows:

• Company formation and capital adequacy. Revised minimum-capital and financial-plan requirements for SRLs, with an enhanced obligation to demonstrate solvency at incorporation. The practical impact for transactions is that buyers must verify the target’s compliance with the new thresholds before signing.
• Director duties and standard of care. The draft codifies a heightened prudence-and-diligence standard and clarifies the duty of loyalty. Directors who fail to act with the care of a “normally prudent and diligent director in similar circumstances” face expanded civil and, in specified cases, criminal exposure.
• Disclosure and CSR obligations. Enhanced annual-reporting requirements aligned with the EU Corporate Sustainability Reporting Directive (CSRD) transposition, affecting mid-cap and large SRLs for the first time.
• Minority-shareholder protections. Lower thresholds for minority shareholders to convene special meetings and request court-appointed auditors, plus revised squeeze-out pricing mechanics for NV/SA entities.
• Governance mechanics. Stricter quorum and notice-period rules for board and shareholder meetings, new mandatory committee structures for companies exceeding defined turnover thresholds, and clarified rules on written resolutions.

Each of these categories has knock-on effects for M&A Belgium 2026 deal structuring, warranty negotiations and post-closing integration. The sections below unpack those effects in actionable detail.

Legislative Timeline and Status

The legislative process in Belgium requires passage through multiple stages before a bill becomes enforceable law. The table below reflects the anticipated trajectory of the draft BCCA amendments based on published parliamentary calendars and practice-note analysis. All dates remain subject to parliamentary scheduling and should be monitored via the Moniteur Belge.

Interaction with Tax and Regulatory Measures

The BCCA amendments do not exist in isolation. Belgium’s fiscal landscape is evolving in parallel, creating compound compliance risk for deal teams. Capital-gains treatment on share disposals by corporate holders is under review, and the mandatory structured e-invoicing regime that Belgium is phasing in adds operational due-diligence requirements to every target assessment. Industry observers expect the combined effect to increase pre-signing compliance costs but to reduce post-closing surprise liabilities, provided diligence is thorough.

Director Duties and Liability in 2026, Civil, Administrative and Criminal Impacts

The director-duties provisions sit at the heart of the 2026 BCCA bill and represent the area of greatest exposure for both sitting directors and acquirers inheriting board liabilities. Understanding company law Belgium 2026 changes in this area is essential for any deal team assessing target-side risk.

The Evolving Standard of Care

Under the current BCCA, directors owe a duty of care measured against the “normally prudent and diligent director placed in the same circumstances” (marginale toetsing). The draft bill retains this formulation but supplements it with three material additions:

• Duty to monitor compliance systems. Directors must demonstrate that they have implemented or supervised adequate internal controls for legal and regulatory compliance, a codification of what Belgian courts had previously inferred from general duty-of-care principles.
• Duty to consider stakeholder interests. Aligned with the CSRD transposition, the bill introduces an express obligation for directors of larger entities to account for the interests of employees, creditors and the environment when making strategic decisions.
• Enhanced reporting to shareholders. Directors must include a dedicated compliance statement in the annual report, confirming adherence to the newly codified duties and disclosing any material non-compliance events during the reporting period.

Criminal Liability Triggers

The draft BCCA bill broadens the circumstances under which director liability may escalate from civil to criminal. Under the current framework, criminal sanctions primarily attach to failures to file annual accounts or to convene mandatory alarm-bell meetings (when net assets fall below prescribed thresholds). The 2026 amendments extend criminal-liability triggers to include wilful failure to implement required compliance-monitoring systems and knowing omission of material facts from the new mandatory compliance statement. The likely practical effect will be a significant increase in directors-and-officers (D&O) insurance claims notifications and higher premium benchmarks.

New Duty Checklist for Boards

Insurance and D&O Implications

Boards should instruct their brokers to review D&O policies now, before the amendments enter into force. Key areas to address include:

• Policy wording. Confirm that “wrongful act” definitions in existing D&O policies capture the newly codified duties, particularly the compliance-monitoring and stakeholder-interest obligations.
• Criminal-defence sub-limits. Given the expanded criminal triggers, ensure that criminal-investigation and defence costs are covered with adequate sub-limits.
• Run-off cover. For directors stepping down pre-completion of an M&A transaction, negotiate tail coverage extending at least 72 months post-resignation to align with the general prescription period for director liability claims under Belgian law.

M&A Implications for Corporate Lawyers Belgium, Due Diligence, Warranties and Indemnities

The BCCA amendments 2026 rewrite the risk matrix for every Belgian M&A transaction. This section addresses the practical adjustments that buyer and seller teams must make to their standard playbooks in light of the evolving corporate governance changes.

Buyer Due Diligence Checklist, Data-Room Focus and Red Flags

Transaction due diligence Belgium exercises should now incorporate the following additional requests and review steps:

• Board-minutes review. Confirm that the target’s board minutes record stakeholder-impact analyses for all strategic decisions taken in the 24 months preceding signing. Absence of these records is a red flag indicating potential director-duty breaches under the amended BCCA.
• Compliance-system documentation. Request the target’s compliance-monitoring framework documents, including committee charters, internal-control policies and any third-party compliance audits.
• Annual compliance statements. Obtain copies of the most recent compliance statements filed with the annual report. Cross-reference disclosed non-compliance events against the warranty disclosure letter.
• Alarm-bell meeting records. Verify whether any alarm-bell meetings were required during the review period and, if so, whether they were properly convened within the statutory timeframe.
• D&O insurance status. Review the target’s D&O policy for coverage gaps relative to the new duties. Factor any required policy upgrade costs into the purchase-price adjustment mechanism.
• Minority-shareholder correspondence. Check for any pending minority-shareholder requests for special meetings or court-appointed auditors, which could delay or complicate closing.

Seller Pre-Deal Remediation Checklist

Sellers preparing for a disposal in the current legislative environment should proactively:

• Conduct a board-governance audit. Engage external counsel to review the past 24 months of board activity against the draft BCCA standards and remedy any documentation gaps before the data room opens.
• Update the articles of association. Ensure the company’s articles reflect current BCCA requirements and, where practicable, anticipate the amendments (for example, by embedding compliance-committee mandates).
• Prepare disclosure schedules early. Draft the warranty disclosure letter in parallel with the data-room population exercise to ensure consistency and reduce negotiation friction.
• Resolve outstanding minority disputes. Address any pending minority-shareholder actions before engaging buyers, as unresolved disputes create contingent liabilities that suppress valuation.

Warranty and Indemnity Clause Adjustments

The table below maps the key warranty topics affected by the 2026 amendments and suggests how draft clauses should be adjusted.

Transaction Structuring and Negotiation Playbook for Corporate Lawyers Belgium

The 2026 amendments shift the calculus for share versus asset deals, indemnity allocation and tax-efficient structuring. Deal teams must adapt their playbooks accordingly.

Share Deals Versus Asset Deals Post-Amendments

Share deals remain the default structure for Belgian M&A because they preserve the target’s legal identity, contracts and permits. However, the expanded director-liability regime makes share deals riskier for buyers inheriting legacy board actions that may not have met the new standard of care. Industry observers expect an uptick in hybrid structures, share deals with carved-out asset transfers for high-risk business lines, and in the use of warranty-and-indemnity (W&I) insurance to bridge the liability gap.

Asset deals, by contrast, allow buyers to cherry-pick compliant operations but trigger transfer taxes and require counterparty consent for key contracts. The tax overlay is material: Belgium applies registration duties on real-property transfers within asset deals, and the evolving capital-gains treatment on share disposals may narrow the after-tax spread between the two structures.

Comparison by Entity Type

Sample Redline Language Suggestions

Below are abbreviated clause templates that deal teams may adapt for their SPAs. These are illustrative and should be tailored by qualified Belgian counsel.

• Compliance-duty representation: “The Seller warrants that, during the Relevant Period, each member of the Board has discharged their duties in compliance with Articles [X] of the BCCA (as amended), including the obligation to implement and supervise adequate compliance-monitoring systems.”
• Director-risk indemnity carve-out: “Notwithstanding the general indemnity cap set out in Clause [Y], the Seller’s indemnity obligations in respect of Losses arising from any breach of the director-duty warranties shall be uncapped / subject to a separate cap of EUR [amount].”
• D&O tail-coverage covenant: “The Buyer shall procure that the Company maintains directors-and-officers insurance with tail coverage of not less than [72] months from Closing for the benefit of outgoing directors, on terms no less favourable than the policy in force at the date of this Agreement.”

Practical Board Actions and Ready Templates

Boards on both the buy-side and sell-side of a transaction should take immediate steps to ensure compliance with the BCCA amendments 2026, even before the bill receives Royal Assent. Early adoption signals governance rigour to counterparties and reduces deal friction.

Sample board-minute paragraph (pre-completion):

“The Board, having considered the proposed transaction and having assessed its impact on the interests of the Company, its shareholders, employees, creditors and the environment in accordance with Articles [X] of the Code of Companies and Associations (as proposed to be amended), and having reviewed the compliance-monitoring report dated [date] prepared by the Compliance Committee, RESOLVES to approve the transaction on the terms set out in the draft Share Purchase Agreement annexed hereto as Appendix [A].”

Sample board resolution, compliance-committee appointment:

“The Board RESOLVES to establish a Compliance Committee comprising [names/roles], with the mandate to (i) oversee the Company’s internal-control framework, (ii) prepare the annual compliance statement for inclusion in the annual report, and (iii) report to the Board at each quarterly meeting on the status of regulatory compliance. The Committee’s charter, attached as Appendix [B], is hereby approved.”

These templates should be reviewed by external Belgian counsel to ensure alignment with the final enacted text. Boards are also advised to engage their statutory auditor (commissaire / commissaris) early in the process, as the auditor may be called upon to verify the compliance statement.

Timeline and Next Steps, Regulatory Dates and Recommended Actions

The following action timetable provides a structured approach for deal teams navigating the transition to the amended BCCA. Timelines are indicative and should be adjusted as the legislative process advances.

Conclusion

The 2026 BCCA amendments mark a watershed moment for company law Belgium 2026 and beyond. For corporate lawyers Belgium transactions depend on, the message is clear: the window between now and entry into force is the time to act. Boards that adopt the new governance standards early will command stronger valuations, face fewer deal-friction points and reduce personal liability exposure. Deal teams that update their diligence requests, warranty packages and indemnity structures now will be positioned to close transactions with confidence, regardless of when the final text receives Royal Assent.

Last reviewed: 9 May 2026. This article will be updated when the BCCA amendment bill receives Royal Assent or material committee amendments are published.

Sources

1. Belgian Official Legal Database / Moniteur Belge (eJustice)
2. PwC Tax Summaries, Belgium
3. PKF, Practice Update
4. Chambers Practice Guide, Belgium (Corporate/M&A)
5. Legal 500, Belgium Corporate & M&A
6. Institute of Company Lawyers (IBJ/IJE)
7. PwC Legal Belgium
8. Deloitte Legal Belgium